EP2136633
Æxliseyðandi kúabóluveiru krabbameinsmeðferð
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
17.3.2008EP published:
28.10.2015EP application number:
08732358.0
EP translation filed:
11.1.2016Grant published:
15.2.2016EPO information:
European Patent Register
Max expiry date:
16.3.2028Expiry date:
16.3.2020
Title:
ONCOLYTIC VACCINIA VIRUS CANCER THERAPY
Timeline
Today
17.3.2008EP application
28.10.2015EP Publication
11.1.2016Translation submitted
15.2.2016Registration published
16.3.2020Expires
Owner
Name:
SillaJen Biotherapeutics, Inc.Address:
450 Sansome Street, Suite 650, 94111, San Francisco, CA, US
Inventor
Name:
KIRN, DavidAddress:
Mill Valley, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
894932 PDate:
15.3.2007Country:
US
Classification
Categories:
A01N 43/04, A01N 63/00, A61K 31/70, A61K 48/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 1.3.2016
Expires: 16.3.2017
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 2.3.2017
Expires: 16.3.2018
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 2.3.2018
Expires: 16.3.2019
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 4.3.2019
Expires: 16.3.2020
Payer: Sigurjónsson & Thor ehf.